🇺🇸 FDA
Patent

US 6946554

Process for the preparation of 9-deazaguanine derivatives

expired A61KA61K31/519A61K31/5377

Quick answer

US patent 6946554 (Process for the preparation of 9-deazaguanine derivatives) held by BioCryst Pharmaceuticals, Inc. expires Mon Sep 15 2025 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
BioCryst Pharmaceuticals, Inc.
Grant date
Tue Sep 20 2005 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 15 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K31/519, A61K31/5377, A61K31/541